Study: Fosamax helps build bone density in osteoporosis patients

08/11/2005 | MSNBC

Merck's Fosamax caused a 31% increase in the density of spine bones among women who had received parathyroid hormone shots to ward off the brittle bone disease, according to a study in the New England Journal of Medicine. The team found using Fosamax slowed the body's natural process of destroying old bones as the parathyroid hormone from NPS Pharmaceuticals increased bone growth.

View Full Article in:

MSNBC

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR